HK Stock MarketDetailed Quotes

02009 BBMG

Watchlist
  • 0.650
  • +0.030+4.84%
Market Closed Apr 26 16:08 CST
6.94BMarket Cap216.67P/E (TTM)

BBMG Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
4.99%107.96B
-8.77%72.6B
-10.72%49.14B
1.72%23.48B
-16.83%102.82B
-8.96%79.58B
-4.64%55.03B
0.63%23.08B
14.47%123.63B
21.67%87.41B
Operating income
4.99%107.96B
-8.77%72.6B
-10.72%49.14B
1.72%23.48B
-16.83%102.82B
-8.96%79.58B
-4.64%55.03B
0.63%23.08B
14.47%123.63B
21.67%87.41B
Operating expenses
-9.72%-95.97B
3.48%-64.74B
6.48%-43.62B
-8.14%-21.31B
15.54%-87.47B
8.35%-67.07B
2.76%-46.65B
-1.53%-19.71B
-18.42%-103.56B
-29.65%-73.18B
Gross profit
-21.96%11.98B
-37.19%7.85B
-34.27%5.51B
-35.80%2.17B
-23.49%15.36B
-12.10%12.5B
-13.91%8.39B
-4.29%3.37B
-2.34%20.07B
-7.59%14.22B
Selling expenses
-1.18%-2.4B
-4.21%-1.83B
-0.91%-1.14B
4.60%-582.87M
10.87%-2.37B
-13.01%-1.75B
2.74%-1.13B
0.94%-610.96M
-13.69%-2.66B
26.86%-1.55B
Administrative expenses
5.64%-6.57B
9.04%-4.35B
-1.32%-3.27B
3.86%-1.48B
-1.69%-6.96B
-3.67%-4.78B
-7.18%-3.22B
3.52%-1.54B
-7.92%-6.84B
-5.99%-4.61B
Research and development expenses
-29.27%-530.17M
-12.47%-475.98M
-32.88%-261M
-35.70%-104.34M
-18.29%-410.14M
-19.33%-423.21M
-9.37%-196.41M
2.36%-76.89M
-28.82%-346.73M
-50.33%-354.67M
Profit from asset sales
-12.09%1.15B
1,327.75%650.49M
1,291.51%619.72M
13.98%172.53M
1,668.85%1.31B
-0.36%45.56M
20.57%44.54M
-55.04%151.37M
53,222.57%73.87M
22.13%45.73M
Revaluation surplus
100.11%1.17B
5.56%338.62M
9.02%336.7M
221.63%13.1M
-15.72%583.06M
23.71%320.78M
28.28%308.85M
104.13%4.07M
32.94%691.81M
1.23%259.3M
-Changes in the fair value of other assets
100.11%1.17B
5.56%338.62M
9.02%336.7M
221.63%13.1M
-15.72%583.06M
23.71%320.78M
28.28%308.85M
104.13%4.07M
32.94%691.81M
1.23%259.3M
Impairment and provision
-54.74%-1.98B
73.24%-50.98M
-33.80%-150.14M
-292.70%-20.84M
6.06%-1.28B
-10.32%-190.54M
37.36%-112.22M
335.10%10.81M
-26.73%-1.36B
18.69%-172.71M
-Other impairment is provision
-54.74%-1.98B
73.24%-50.98M
-33.80%-150.14M
-292.70%-20.84M
6.06%-1.28B
-10.32%-190.54M
37.36%-112.22M
335.10%10.81M
-26.73%-1.36B
18.69%-172.71M
Special items of operating profit
-18.45%705.26M
-20.17%552.06M
-15.89%363.26M
87.62%92.54M
-48.29%864.84M
-22.50%691.56M
-40.27%431.91M
-65.87%49.32M
6.65%1.67B
-15.55%892.37M
Operating profit
-58.19%2.43B
-60.39%2.1B
-55.38%1.65B
-105.69%-48.66M
-38.97%5.82B
-30.08%5.3B
-31.67%3.69B
-34.43%855.83M
-9.98%9.53B
-12.07%7.58B
Financing cost
15.35%-2.28B
-5.11%-2.08B
14.53%-1.3B
-22.08%-695.24M
-13.34%-2.69B
-9.54%-1.98B
-11.11%-1.52B
20.82%-569.49M
24.96%-2.37B
27.52%-1.8B
Special items of earning before tax
-26.52%144.02M
-92.79%81.31M
-93.93%72.6M
-39.56%18.32M
-72.84%195.99M
89.37%1.13B
220.53%1.2B
-37.92%30.31M
96.44%721.54M
371.85%595.65M
Earning before tax
-90.97%300.39M
-97.66%103.97M
-87.39%425.68M
-329.14%-725.58M
-57.81%3.33B
-30.13%4.45B
-23.56%3.37B
-50.13%316.65M
1.10%7.88B
1.82%6.37B
Tax
-0.17%-1.59B
61.46%-522.85M
56.96%-411.02M
23.06%-117.58M
40.58%-1.59B
24.61%-1.36B
20.10%-954.98M
31.38%-152.82M
-1.11%-2.67B
1.73%-1.8B
After-tax profit from continuing operations
-173.99%-1.29B
-113.54%-418.88M
-99.39%14.66M
-614.66%-843.15M
-66.62%1.74B
-32.30%3.09B
-24.85%2.42B
-60.26%163.83M
1.10%5.21B
3.28%4.57B
Earning after tax
-173.99%-1.29B
-113.54%-418.88M
-99.39%14.66M
-614.66%-843.15M
-66.62%1.74B
-32.30%3.09B
-24.85%2.42B
-60.26%163.83M
1.10%5.21B
3.28%4.57B
Minority profit
-348.98%-1.31B
-156.16%-429.49M
-167.71%-395.4M
-357.32%-511.5M
-76.87%527.21M
-58.76%764.79M
-55.34%583.95M
-158.48%-111.85M
-1.40%2.28B
8.50%1.85B
Profit attributable to shareholders
-97.92%25.26M
-99.54%10.61M
-77.66%410.06M
-220.30%-331.65M
-58.65%1.21B
-14.25%2.33B
-3.99%1.84B
24.77%275.67M
3.14%2.93B
0.00%2.72B
Basic earnings per share
-98.18%0.002
-98.08%0.0025
-200.00%-0.03
-59.26%0.11
-7.14%0.13
50.00%0.03
0.00%0.27
0.00%0.25
Diluted earnings per share
-98.18%0.002
-98.08%0.0025
-200.00%-0.03
-59.26%0.11
-7.14%0.13
50.00%0.03
0.00%0.27
0.00%0.25
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover 4.99%107.96B-8.77%72.6B-10.72%49.14B1.72%23.48B-16.83%102.82B-8.96%79.58B-4.64%55.03B0.63%23.08B14.47%123.63B21.67%87.41B
Operating income 4.99%107.96B-8.77%72.6B-10.72%49.14B1.72%23.48B-16.83%102.82B-8.96%79.58B-4.64%55.03B0.63%23.08B14.47%123.63B21.67%87.41B
Operating expenses -9.72%-95.97B3.48%-64.74B6.48%-43.62B-8.14%-21.31B15.54%-87.47B8.35%-67.07B2.76%-46.65B-1.53%-19.71B-18.42%-103.56B-29.65%-73.18B
Gross profit -21.96%11.98B-37.19%7.85B-34.27%5.51B-35.80%2.17B-23.49%15.36B-12.10%12.5B-13.91%8.39B-4.29%3.37B-2.34%20.07B-7.59%14.22B
Selling expenses -1.18%-2.4B-4.21%-1.83B-0.91%-1.14B4.60%-582.87M10.87%-2.37B-13.01%-1.75B2.74%-1.13B0.94%-610.96M-13.69%-2.66B26.86%-1.55B
Administrative expenses 5.64%-6.57B9.04%-4.35B-1.32%-3.27B3.86%-1.48B-1.69%-6.96B-3.67%-4.78B-7.18%-3.22B3.52%-1.54B-7.92%-6.84B-5.99%-4.61B
Research and development expenses -29.27%-530.17M-12.47%-475.98M-32.88%-261M-35.70%-104.34M-18.29%-410.14M-19.33%-423.21M-9.37%-196.41M2.36%-76.89M-28.82%-346.73M-50.33%-354.67M
Profit from asset sales -12.09%1.15B1,327.75%650.49M1,291.51%619.72M13.98%172.53M1,668.85%1.31B-0.36%45.56M20.57%44.54M-55.04%151.37M53,222.57%73.87M22.13%45.73M
Revaluation surplus 100.11%1.17B5.56%338.62M9.02%336.7M221.63%13.1M-15.72%583.06M23.71%320.78M28.28%308.85M104.13%4.07M32.94%691.81M1.23%259.3M
-Changes in the fair value of other assets 100.11%1.17B5.56%338.62M9.02%336.7M221.63%13.1M-15.72%583.06M23.71%320.78M28.28%308.85M104.13%4.07M32.94%691.81M1.23%259.3M
Impairment and provision -54.74%-1.98B73.24%-50.98M-33.80%-150.14M-292.70%-20.84M6.06%-1.28B-10.32%-190.54M37.36%-112.22M335.10%10.81M-26.73%-1.36B18.69%-172.71M
-Other impairment is provision -54.74%-1.98B73.24%-50.98M-33.80%-150.14M-292.70%-20.84M6.06%-1.28B-10.32%-190.54M37.36%-112.22M335.10%10.81M-26.73%-1.36B18.69%-172.71M
Special items of operating profit -18.45%705.26M-20.17%552.06M-15.89%363.26M87.62%92.54M-48.29%864.84M-22.50%691.56M-40.27%431.91M-65.87%49.32M6.65%1.67B-15.55%892.37M
Operating profit -58.19%2.43B-60.39%2.1B-55.38%1.65B-105.69%-48.66M-38.97%5.82B-30.08%5.3B-31.67%3.69B-34.43%855.83M-9.98%9.53B-12.07%7.58B
Financing cost 15.35%-2.28B-5.11%-2.08B14.53%-1.3B-22.08%-695.24M-13.34%-2.69B-9.54%-1.98B-11.11%-1.52B20.82%-569.49M24.96%-2.37B27.52%-1.8B
Special items of earning before tax -26.52%144.02M-92.79%81.31M-93.93%72.6M-39.56%18.32M-72.84%195.99M89.37%1.13B220.53%1.2B-37.92%30.31M96.44%721.54M371.85%595.65M
Earning before tax -90.97%300.39M-97.66%103.97M-87.39%425.68M-329.14%-725.58M-57.81%3.33B-30.13%4.45B-23.56%3.37B-50.13%316.65M1.10%7.88B1.82%6.37B
Tax -0.17%-1.59B61.46%-522.85M56.96%-411.02M23.06%-117.58M40.58%-1.59B24.61%-1.36B20.10%-954.98M31.38%-152.82M-1.11%-2.67B1.73%-1.8B
After-tax profit from continuing operations -173.99%-1.29B-113.54%-418.88M-99.39%14.66M-614.66%-843.15M-66.62%1.74B-32.30%3.09B-24.85%2.42B-60.26%163.83M1.10%5.21B3.28%4.57B
Earning after tax -173.99%-1.29B-113.54%-418.88M-99.39%14.66M-614.66%-843.15M-66.62%1.74B-32.30%3.09B-24.85%2.42B-60.26%163.83M1.10%5.21B3.28%4.57B
Minority profit -348.98%-1.31B-156.16%-429.49M-167.71%-395.4M-357.32%-511.5M-76.87%527.21M-58.76%764.79M-55.34%583.95M-158.48%-111.85M-1.40%2.28B8.50%1.85B
Profit attributable to shareholders -97.92%25.26M-99.54%10.61M-77.66%410.06M-220.30%-331.65M-58.65%1.21B-14.25%2.33B-3.99%1.84B24.77%275.67M3.14%2.93B0.00%2.72B
Basic earnings per share -98.18%0.002-98.08%0.0025-200.00%-0.03-59.26%0.11-7.14%0.1350.00%0.030.00%0.270.00%0.25
Diluted earnings per share -98.18%0.002-98.08%0.0025-200.00%-0.03-59.26%0.11-7.14%0.1350.00%0.030.00%0.270.00%0.25
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg